{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:05:25Z","timestamp":1770750325833,"version":"3.50.0"},"reference-count":44,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Increasing testing is key to achieving hepatitis C elimination. This retrospective study aimed to assess the testing cascade of patients at a regional hospital in Victoria, Australia, who inject drugs or are living with hepatitis C, to identify missed opportunities for hepatitis C care. Adult hospital inpatients and emergency department (ED) attendees from 2018 to 2021 with indications for intravenous drug use (IDU) or hepatitis C on their discharge or ED summary were included. Data sources: hospital admissions, pathology, hospital pharmacy, and outpatients. We assessed progression through the testing cascade and performed logistic regression analysis for predictors of hepatitis C care, including testing and treatment. Of 79,923 adults admitted, 1345 (1.7%) had IDU-coded separations and 628 (0.8%) had hepatitis C-coded separations (N = 1892). Hepatitis C virus (HCV) status at the end of the study was unknown for 1569 (82.9%). ED admissions were associated with increased odds of not providing hepatitis C care (odds ratio 3.29, 95% confidence interval 2.42\u20134.48). More than 2% of inpatients at our hospital have an indication for testing, however, most are not being tested despite their hospital contact. As we work toward HCV elimination in our region, we need to incorporate testing and linkage strategies within hospital departments with a higher prevalence of people at risk of infection.<\/jats:p>","DOI":"10.3390\/v16060979","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T11:10:28Z","timestamp":1718968228000},"page":"979","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Missed Opportunities: A Retrospective Study of Hepatitis C Testing in Hospital Inpatients"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3516-887X","authenticated-orcid":false,"given":"Christine","family":"Roder","sequence":"first","affiliation":[{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"},{"name":"Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Cosgrave","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Barwon Health, Geelong 3220, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Mackie","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Barwon Health, Geelong 3220, Australia"},{"name":"Pharmacy Department, Alfred Health, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3539-4153","authenticated-orcid":false,"given":"Bridgette","family":"McNamara","sequence":"additional","affiliation":[{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"},{"name":"Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong 3220, Australia"},{"name":"Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne 3010, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"},{"name":"Department of Infectious Disease, Alfred Health, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J.","family":"Wade","sequence":"additional","affiliation":[{"name":"Barwon South West Public Health Unit, Barwon Health, Geelong 3220, Australia"},{"name":"Centre for Innovation in Infectious Disease and Immunology Research (CIIDIR), Institute for Mental and Physical Health and Clinical Translation (IMPACT), School of Medicine, Deakin University, Geelong 3220, Australia"},{"name":"Disease Elimination Program, Burnet Institute, Melbourne 3004, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40258-018-0392-8","article-title":"Uptake of and expenditure on direct-acting antiviral agents for hepatitis C treatment in Australia","volume":"16","author":"Yee","year":"2018","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S2055-6640(20)30253-3","article-title":"Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: A geospatial analysis of a year of unrestricted treatment access","volume":"4","author":"Scott","year":"2018","journal-title":"J. Virus Erad."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/cid\/ciab526","article-title":"Opportunities to enhance linkage to hepatitis C care among hospitalized people with recent drug dependence in New South Wales, Australia: A population-based linkage study","volume":"73","author":"Valerio","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jvh.12910","article-title":"Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C","volume":"25","author":"Wade","year":"2018","journal-title":"J. Viral Hepat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jvh.13622","article-title":"Psychiatrists can treat hepatitis C","volume":"28","author":"Roder","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.15107","article-title":"A multi-site, nurse-coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia","volume":"42","author":"Harney","year":"2022","journal-title":"Liver Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/jvh.13487","article-title":"Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care","volume":"28","author":"Harney","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_9","unstructured":"Burnet Institute and Kirby Institute (2022). Australia\u2019s Progress towards Hepatitis C Elimination: Annual Report 2022, Burnet Institute."},{"key":"ref_10","unstructured":"King, J., and McManus, H. (2023). HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2023, Kirby Institute, UNSW Sydney."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.07.006","article-title":"Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade","volume":"47","author":"Scott","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"ref_12","first-page":"247","article-title":"Micro-elimination: A key component of global hepatitis C elimination","volume":"Volume 1","author":"Hatzakis","year":"2021","journal-title":"Hepatitis C: Epidemiology, Prevention and Elimination"},{"key":"ref_13","first-page":"365","article-title":"Australia needs to increase testing to achieve hepatitis C elimination","volume":"212","author":"Scott","year":"2020","journal-title":"MJA"},{"key":"ref_14","unstructured":"MacLachlan, J., Stewart, S., and Cowie, B. (2020). Viral Hepatitis Mapping Project: National Report 2020, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)."},{"key":"ref_15","unstructured":"Wade, A.J., and Inthavong, P. (2024, June 17). Viral Hepatitis Notifications: An Assessment of Place-Based Management in Victoria. [Oral presentation]. Communicable Diseases and Immunization Conference, Brisbane QLD Australia. Available online: https:\/\/www.cdic2024.com\/_files\/ugd\/a52314_78c2720fa39c433bbd488d2f3b970096.pdf#page=262.00."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: Strategic and operational considerations","volume":"Volume 38","author":"Lazarus","year":"2018","journal-title":"Seminars in Liver Disease"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/hiv.13328","article-title":"Blood-borne virus testing in emergency departments\u2014A systematic review of seroprevalence, feasibility, acceptability and linkage to care","volume":"24","author":"Simmons","year":"2023","journal-title":"HIV Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Rosato, V., and Kondili, L.A. (2022). Elimination of hepatitis C in Southern Italy: A model of HCV screening and linkage to care among hospitalized patients at different hospital divisions. Viruses, 14.","DOI":"10.3390\/v14051096"},{"key":"ref_19","first-page":"E413","article-title":"The Hepatitis C Clinical Exchange Network: A Local Health Department Partnership With Acute Care Hospitals to Promote Screening and Treatment of Hepatitis C Virus Infection","volume":"28","author":"Moore","year":"2022","journal-title":"JPHMP"},{"key":"ref_20","unstructured":"Barwon Health (2024, June 06). Service Profile. Available online: https:\/\/www.barwonhealth.org.au\/about-us\/service-profile."},{"key":"ref_21","unstructured":"Barwon South West Public Health Unit (2023). Population Health Catchment Plan 2023\u20132029, Barwon South West Public Health Unit."},{"key":"ref_22","unstructured":"Hepatitis C Virus Infection Consensus Statement Working Group (2022). Australian Recommendations for the Management of Hepatitis C Virus Infection: A consensus Statement, Gastroenterological Society of Australia (GESA)."},{"key":"ref_23","unstructured":"(2024, June 06). The QuickStart Study. Available online: https:\/\/www.burnet.edu.au\/research\/projects\/the-quickstart-study\/."},{"key":"ref_24","unstructured":"(2019, June 19). International Statistical Classification If Diseases and Related Health Problems. Available online: https:\/\/icd.who.int\/browse10\/2019\/en."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/dar.13471","article-title":"Hospitalisation with injection-related infections: Validation of diagnostic codes to monitor admission trends at a tertiary care hospital in Melbourne, Australia","volume":"41","author":"Curtis","year":"2022","journal-title":"Drug Alcohol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lambert, J.S., and Murtagh, R. (2019). \u2018HepCheck Dublin\u2019: An intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3748-2"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Roder, C., and Cosgrave, C. (2023). Leave No-One Behind: A Retrospective Study of Hepatitis C Testing and Linkage to Care for Hospital Inpatients. Viruses, 15.","DOI":"10.3390\/v15040913"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2468-1253(21)00471-4","article-title":"Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: A systematic review and meta-analysis","volume":"7","author":"Cunningham","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/hiv.12364","article-title":"Incorporating HIV\/hepatitis B virus\/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: The \u201cGoing Viral\u201d campaign","volume":"17","author":"Orkin","year":"2016","journal-title":"HIV Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19257","DOI":"10.1038\/s41598-022-23602-1","article-title":"Real-world clinical effectiveness and sustainability of universal bloodborne virus testing in an urban emergency department in the UK","volume":"12","author":"Smout","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_31","first-page":"469","article-title":"High prevalence of hepatitis C infection among adult patients at four urban emergency departments\u2014Birmingham, Oakland, Baltimore, and Boston, 2015\u20132017","volume":"69","author":"Galbraith","year":"2020","journal-title":"MMWR"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s10620-021-06941-3","article-title":"Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment","volume":"67","author":"Le","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jvh.13393","article-title":"Screening emergency admissions at risk of chronic hepatitis C (SEARCH) to diagnose or \u2018re-diagnose\u2019 infections is effective in Australia","volume":"28","author":"Prince","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12962-022-00388-7","article-title":"Universal testing for hepatitis B and hepatitis C in the emergency department: A cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom","volume":"20","author":"Williams","year":"2022","journal-title":"Cost. Eff. Resour. Alloc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41575-022-00647-1","article-title":"Ten steps to eliminating hepatitis C in hospitals","volume":"19","author":"Calleja","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/jvh.13399","article-title":"Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination","volume":"27","author":"Drenth","year":"2020","journal-title":"J. Viral Hepat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/cid\/ciad711","article-title":"Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial","volume":"78","author":"Midgard","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Conway, A., and Valerio, H. (2022). A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study. Viruses, 14.","DOI":"10.3390\/v14071555"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jvh.13888","article-title":"What is the impact of a Hepatitis C \u2018test, trace and treat\u2019 pilot using peer workers?","volume":"30","author":"Caroline","year":"2023","journal-title":"J. Viral Hepat."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Clark, P.J., and Valery, P.C. (2022). Hepatitis C treatment outcomes for Australian First Nations Peoples: Equivalent SVR rate but higher rates of loss to follow-up. BMC Gastroenterol., 22.","DOI":"10.1186\/s12876-022-02416-5"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100279","DOI":"10.1016\/j.jhepr.2021.100279","article-title":"Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy","volume":"3","author":"Girardin","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gofton, C., and Bondezi, K. (2024). Micro-elimination of chronic hepatitis C virus in mental health settings: A prospective multicentre pragmatic trial. Drug Alcohol. Rev., ahead of print.","DOI":"10.1111\/dar.13854"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1753-6405.13109","article-title":"Pregnancy\u2013a key moment for engaging women with hepatitis B in care","volume":"45","author":"Roder","year":"2021","journal-title":"Aust. N. Z. J. Public Health"},{"key":"ref_44","unstructured":"(2021, August 10). Australian Bureau of Statistics, ABS Maps, Available online: https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026\/access-and-downloads\/abs-maps."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/6\/979\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:00:37Z","timestamp":1760108437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/6\/979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["v16060979"],"URL":"https:\/\/doi.org\/10.3390\/v16060979","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}